Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan in Migraine with Unilateral Autonomic Symptoms
NCT00753311Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jul 2009
- Primary completion
- Nov 2010
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rizatriptan in migraine, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Pain Freedom at 2 Hours Post-dose. Started Jul 2009; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00753311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753311.